SJT Molecular 

Family of molecules with oral therapeutic potential in NAFLD, NASH, obesity, hypertension and type 2 diabetes

OWNER

Antonio Exposito (See Profile)


OWNER

Antonio Exposito (See Profile)


OWNER

Juan Carlos Agreda (See Profile)


OWNER

Vicenc Tur (See Profile)


Sector

Drug Discovery

Stage

Prototyping, preclinical

Country

Spain


STRONG IP PORTFOLIO WITH LONG EXPIRY DATES GRANTED IN EEUU, EUROPE, ASIA AND OTHER MAJOR MARKETS

SJT MOLECULES REDUCE OBESITY, HEPATIC STEATOSIS, NASH, DIABETES, CHOLESTEROL AND HYPERTENSION, ALL PRIORITY PATHOLOGIES

OUR MOLECULES ARE SAFE, EFFECTIVE & HAVE A LOW MANUFACTURING COST DUE TO AN EASY CHEMICAL SYNTHESIS PROCESS (4 STEPS)

THE INTEREST HAS BEEN DEMONSTRATED BY THE 20 NDAS SIGNED WITH BIG PHARMAS IN BIOS & JP MORGAN IN LAST YEARS

“FIRST-IN-CLASS” NOVEL DUAL MECHANISM OF ACTION (FXR AGONIST + 5-HTR2A ANTAGONIST)

Status

Approved

IP Type

Patent

Time

Countries

Australia
Austria
Belgium
Canada
China
Denmark
Finland
France
Germany
Israel
Italy
Japan
Netherlands
Russia
South Korea
Spain
Switzerland
USA
United Kingdom

Coverage

Product patent with composition of matter claims for the family of products in development and also with medical use claims, pharmaceutical formulations and cosmetic, nutraceutical and veterinary uses of the protected products.

Know more of this patent

Status

Approved

IP Type

Patent

Time

20 years

Countries

Austria
Belgium
Canada
Denmark
Finland
France
Germany
Italy
Japan
Netherlands
South Korea
Spain
Switzerland
USA
United Kingdom

Coverage

Additional layer of medical use patent for NAFLD and NASH of SJT’s lead compound and main backup products

Know more of this patent

This information is confidential, do not share or copy.

Under evaluation at least till: May 20th, 2022

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2022 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar